Abdennour Ferhat, MD

Global Medical Affairs Leader, GI/Emerging Portfolio, Oncology, OBU Medical
AstraZeneca, United Kingdom

Poster(s):

• (335) Patient characteristics, treatment patterns, and real-world outcomes among patients in the US with human epidermal growth factor receptor 2 (HER2)-expressing solid tumors
  Wednesday, October 29, 2025